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ABSTRACT
Aqueous and ethanolic extracts of ten traditional
Thai medicinal plants were investigated for their
ability to inhibit 35 hospital isolates of methicillin-
resistant Staphylococcus aureus (MRSA). Nine
medicinal plants displayed activity against all
isolates tested. Ethanolic extracts of Garcinia
mangostana, Punica granatum and Quercus infectoria
were most effective, with MICs for MRSA isolates
of 0.05–0.4, 0.2–0.4 and 0.2–0.4 mg ⁄mL, respect-
ively, and for S. aureus ATCC 25923 of 0.1, 0.2 and
0.1 mg ⁄mL, respectively. MBCs for MRSA iso-
lates were 0.1–0.4, 1.6–3.2 and 0.4–1.6 mg ⁄mL,
and for S. aureus ATCC 25923 were 0.4, 3.2 and
1.6 mg ⁄mL, respectively.
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The investigation of traditionally used plants for
biologically active extracts has been well-docu-
mented. Recent studies [1–12] have revealed that
medicinal plants from various parts of the world
can provide a rich source of antibacterial activ-
ities. In Thailand, many plant species have been
used widely to cure infectious diseases. Such
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plants are available locally, are inexpensive,
and have become increasingly popular. The
aim of the present study was to screen plant
extracts that have been shown earlier to have
antibacterial activity [4,5] against hospital iso-
lates of methicillin-resistant Staphylococcus aureus
(MRSA).
Plants were collected and identiﬁed by Thai
herbalists, and specimens were deposited at the
Herbarium of Prince of Songkla University, Thai-
land. Preparation of the plant extracts used in this
investigation was as described previously [4,5].
Aqueous extracts were dissolved in water, while
ethanolic extracts were dissolved in dime-
thylsulphoxide before use. Thirty-ﬁve clinical
isolates of MRSA (PSU 0201–PSU 0235) were
kindly provided by Hatyai Hospital, Songkla,
Thailand. S. aureus ATCC 25923 was used as a
reference strain.
Sterile 5-mm-diameter ﬁlter paper disks (What-
man no. 1; Whatman, Maidstone, UK) were
soaked with 10 lL of extract residue, and diluted
in the corresponding solvent to a concentration of
250 mg ⁄mL; thus each disk contained 2.5 mg of
residue. Both wet and dry (dried at 37C over-
night) disks were placed on the surface of Muel-
ler–Hinton agar (MHA; Difco, Le Pont-De-Claix,
France) plates seeded with c. 108 CFU of the
tested isolates grown overnight in Trypticase
Soy broth (Oxoid, Basingstoke, UK). Antibac-
terial activity was evaluated by measuring the
diameter of the inhibition zone. Each experi-
ment was performed in triplicate and the mean
of the diameters of the inhibition zones was
calculated.
A modiﬁed agar dilution method with milli-
pore ﬁlters [13] was used to determine the MICs
of aqueous and ethanolic extracts of medicinal
plants that produced inhibition zones. For each
bacterial strain, 1 lL of culture (containing
c. 104 CFU) was applied to a millipore ﬁlter on
MHA supplemented with the medicinal plant
extracts at concentrations ranging from 0.12 to
250 mg ⁄mL. The plates were incubated at 35C
for 18 h. Experiments were performed in tripli-
cate and the results were expressed as the lowest
concentration of plant extract that produced
complete suppression of colony growth. MBCs
were determined with the extracts that gave
signiﬁcant inhibition by removing the millipore
ﬁlter and placing it on a fresh MHA plate.
Of 16 crude aqueous and ethanolic plant
extracts, 14 (87.5%) extracts of nine plant species
had activity against the 35 MRSA isolates tested
(Table 1). Only extracts of Tamarindus indica were
inactive against all isolates. The inhibition zones
ranged from 6 to 22 mm, but there were signiﬁ-
cant differences in the inhibition zones produced
by aqueous and ethanolic extracts of the same
plant species. Signiﬁcant antibacterial effects,
expressed as MICs and MBCs, of crude extracts
against the 35 isolates of MRSA are listed in
Table 2. Ethanolic extracts of Garcinia mangostana
were among the most active against the MRSA
isolates, with MICs and MBCs of 0.05–0.4 and
0.1–0.4 mg ⁄mL, respectively. Aqueous and etha-
nolic extracts of Quercus infectoria also showed
good activity against all MRSA isolates, with
MICs and MBCs of 0.2–0.4 and 0.4–1.6 mg ⁄mL,
respectively.
In conclusion, this preliminary evaluation indi-
cated that certain medicinal plants, especially
G. mangostana and Q. infectoria, possessed signiﬁ-
cant activity against MRSA isolates. This activity
may be indicative of the presence of metabolic
toxins or broad-spectrum antibacterial com-
pounds. Of the medicinal plants investigated in
this study, G. mangostana and Punica granatum are
known to possess high amounts of tannin, and the
antimicrobial property of this substance is well-
Table 1. Antibacterial activity of crude medicinal plant
extracts against isolates of methicillin-resistant Staphylo-
coccus aureus (MRSA)
Medicinal plant
extract
(2.5 mg ⁄disk)
Mean ± standard error inhibition zone (mm)
Aqueous extract Ethanolic extract
MRSA
S. aureus
ATCC 25923 MRSA
S. aureus
ATCC 25923
Acacia catechu 8.83 ± 0.35a 7 10.67 ± 0.19 10
9.17 ± 0.35b 6 19.25 ± 1.24 10
Garcinia mangostana ND ND 10.43 ± 0.20a
11.51 ± 0.17b
11
12
Impatiens balsamina ND ND 9.42 ± 0.19a
9.75 ± 0.25b
6
8
Peltophorum ptercarpum ND ND 11.00 ± 0.24a
12.08 ± 0.15b
12
13
Psidium guajava 14.42 ± 0.55a 15 9.75 ± 0.18 11
15.00 ± 0.62b 16 9.92 ± 0.29 10
Punica granatum 15.75 ± 0.43a 17 16.70 ± 0.17 17
17.92 ± 0.34b 18 18.53 ± 0.57 18
Quercus infectoria 18.50 ± 0.57a 18 17.97 ± 0.24 17
19.85 ± 0.61b 19 19.23 ± 0.20 18
Tamarindus indica 0 0 0 0
Uncaria gambir 13.08 ± 0.53a 13 19.33 ± 0.26 17
16.50 ± 0.46b 14 21.50 ± 0.48 19
Walsura robusta ND ND 10.25 ± 0.28a
12.25 ± 0.25b
12
12
aDry disk; bwet disk.
ND, not done.
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known. However, the present study is the ﬁrst
report of the activity of extracts from Q. infectoria
against MRSA. The results presented in this
report suggest that this plant extract should be
analysed further, as it might provide a new
compound effective against multiresistant S. au-
reus infections. Such simple and inexpensive
alternatives to conventional treatment of bacterial
infections may be worthy of further rigorous
investigation. It has already been reported that tea
leaf extract gives results equivalent to conven-
tional antibiotics in the therapy of impetigo
contagiosa [14], while Bassett et al. [15] have
reported favourable results with tea-tree oil in
the treatment of acne. It can be speculated that Q.
infectoria extract may be effective in the form of a
nasal ointment or body wash, but much more
experimental work is needed.
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Table 2. MICs and MBCs of crude
medicinal plant extracts against iso-
lates of methicillin-resistant Staphy-
lococcus aureus (MRSA)
Medicinal
plant extract
MIC ⁄MBC (mg ⁄mL)
Aqueous extract Ethanolic extract
MRSA
S. aureus
ATCC 25923 MRSA
S. aureus
ATCC 25923
Acacia catechu 6.3–12.5 ⁄ 12.5–25 3.2 ⁄ 25 1.6–3.2 ⁄ 25 1.6 ⁄ 12.5
Garcinia mangostana ND ND 0.05–0.4 ⁄ 0.1–0.4 0.1 ⁄ 0.4
Impatiens balsamina ND ND 6.3 ⁄ 25 6.3 ⁄ 25
Peltophorum ptercarpum ND ND 0.1–0.8 ⁄ 6.3 0.1 ⁄ 3.2
Psidium guajava 0.8–1.6 ⁄ 6.3 0.8 ⁄ 6.3 0.2–1.6 ⁄ 6.3 0.2 ⁄ 1.6
Punica granatum 0.4–1.6 ⁄ 6.3–12.5 0.4 ⁄ 6.3 0.2–0.4 ⁄ 1.6–3.2 0.2 ⁄ 3.2
Quercus infectoria 0.2–0.4 ⁄ 0.4–1.6 0.2 ⁄ 1.6 0.2–0.4 ⁄ 0.4–1.6 0.1 ⁄ 1.6
Tamarindus indica ND ND ND ND
Uncaria gambir 6.3–12.5 ⁄ 12.5–25 3.2 ⁄ 25 0.4–0.8 ⁄ 3.2 0.4 ⁄ 3.2
Walsura robusta ND ND 1.6–3.2 ⁄ 25 1.6 ⁄ 25
ND, not done.
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